Pharmafile - Medical Communications News
European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium ...
Widespread protests against racism and police brutality did not cause a significant spike in coronavirus cases in the US, according to new research.
Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part of their BNT162 RNA-based...
Texas becomes the latest state in the US to mandate the wearing of facemasks in public, as COVID-19 cases skyrocket across the country.
Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s drug remdesivir, which is one of the...
The city of Leicester has been locked down after seeing a surge in COVID-19 cases. This surge is visible in Pillar 2 data now released, but not the...
Featuring focuses on the importance of pharmaceutical sustainability and the economics of the revolutionary but deeply expensive CAR T cancer therapy...
NICE are set to recommend Roche’s Rozlytrek (Entrectinib) cancer treatment which will be the second histology drug to be recommended for use on the...
Novartis and its former eye care unit Alcon have agreed to pay a combined $347 million to resolve allegations that the companies ran bribery schemes...
More than two thirds of black, Asian and minority ethnic pharmacists have not had any workplace risk assessments for COVID-19, according to a recent...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
